Gresham makes 12x return from drug company

Buyout firm Gresham Private Equity has sold Penn Pharmaceuticals after increasing profits tenfold.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this